Sterling Capital Management’s Cogent Biosciences COGT Stock Holding History

Sterling Capital Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$176K	Buy	5,502 +4,916	+839%	+$182K	﹤0.01%	1188
2026 Q2	$22.7K	Sell	586 -567	-49%	-$19.8K	﹤0.01%	1829
2026 Q1	$44.4K	Sell	1,153 -165	-13%	-$6.09K	﹤0.01%	1686
2025 Q4	$46.8K	Buy	1,318 +499	+61%	+$14K	﹤0.01%	1830
2025 Q3	$11.8K	Buy	819 +466	+132%	+$5.52K	﹤0.01%	2403
2025 Q2	$2.54K	Buy	353 +155	+78%	+$859	﹤0.01%	2853
2025 Q1	$1.19K	Sell	198 -107	-35%	-$839	﹤0.01%	2759
2024 Q4	$2.38K	Buy	305 +198	+185%	+$1.97K	﹤0.01%	2736
2024 Q3	$1.16K	Buy	+107	New	+$1.04K	﹤0.01%	2454

Other funds holding COGT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Sterling Capital Management's COGT Position: Q3 2026 in Review

Sterling Capital Management increased its Cogent Biosciences (COGT) stake by 839% in Q3 2026, buying an estimated $182K and bringing the position to 5,502 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Sterling Capital Management first reported a position in COGT in Q3 2024 and has held it in 9 quarters since. 87 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

Sterling Capital Management held 5,502 shares of Cogent Biosciences worth $176K as of Q3 2026.
Sterling Capital Management bought 4,916 Cogent Biosciences shares in Q3 2026, an estimated $182K.
Cogent Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1188 holding.
Sterling Capital Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 9 quarters since.
87 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.